- 专利标题： CD133 related to anticancer agent resistance in colon cancer and use thereof
-
申请号： US16848273申请日： 2020-04-14
-
公开(公告)号： US11639530B2公开(公告)日： 2023-05-02
- 发明人: Je Sang Ko , Min-Soo Kang
- 申请人： KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
- 申请人地址： KR Seoul
- 专利权人： KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
- 当前专利权人： KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
- 当前专利权人地址： KR Seoul
- 代理机构： Sughrue Mion, PLLC
- 优先权： KR10-2019-0043765 20190415
- 主分类号： C12N15/113
- IPC分类号： C12N15/113 ; C12Q1/6886 ; A61K48/00 ; A61K45/06 ; C12N5/00
摘要：
The present invention relates to a use of CD133 involved in resistance to an EGFR-targeting agent in colon cancer. The CD133 protein may be used as a novel target protein for diagnosing and treating resistant cancer as well as general cancer.
公开/授权文献
信息查询
IPC分类:
